SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-003287
Filing Date
2024-02-07
Accepted
2024-02-07 08:00:23
Documents
15
Period of Report
2024-02-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 FORM 8-K omer20230913_8k.htm   iXBRL 8-K 30322
  Complete submission text file 0001437749-24-003287.txt   164086

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA omer-20240201.xsd EX-101.SCH 3409
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE omer-20240201_def.xml EX-101.DEF 11424
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE omer-20240201_lab.xml EX-101.LAB 15310
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE omer-20240201_pre.xml EX-101.PRE 11584
16 EXTRACTED XBRL INSTANCE DOCUMENT omer20230913_8k_htm.xml XML 2824
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

IRS No.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34475 | Film No.: 24602234
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)